Navigation Links


SPM278 in Biological Products

Mouse Anti-67kD Laminin Receptor Prediluted Monoclonal Antibody, Unconjugated, SPM278 from GeneTex

Description: Product Mouse monoclonal [SPM278] to 67kD Laminin Receptor, prediluted Immunogen Small cell lung carcinoma N592 live cells (Human). Reactivity / Specificity Cross-reacts with Human. Not yet tested in other species. Background Information Laminin, one of the major glycoproteins of basement m...
Company:GeneTex
SPM278 in other areas

67kDa Laminin receptor antibody, 67kDa Laminin receptor [SPM278 ...

Buy quality mouse 67kDa Laminin receptor antibody (interacts with human - not yet tested in other species), anti-67kDa Laminin receptor, 67kDa Laminin receptor ...

Antibody Products - IgG Monoclonal Antibodies - GenWay

Buy quality IgG products, IgG Monoclonal Antibody, Rabbit IgG Antibody, anti-IgG ... Mouse monoclonal [SPM278] to 67kD Laminin Receptor, prediluted; 3921; RPSA; ...

Anti-Laminin Receptor, 67kD Antibodies - Antibody Search - Biocompare ...

Mouse Anti-67kD Laminin Receptor Monoclonal Antibody, Unconjugated, Clone SPM278 ... Anti-Human 67kD Laminin Receptor Monoclonal antibody, Unconjugated, Clone spm278 ...

Anti-Laminin Receptor Antibodies - Antibody Search - Biocompare Buyer's ...

Mouse Anti-Human Laminin Receptor Monoclonal Antibody, Unconjugated, Clone SPM278 ... Mouse Anti-Laminin-R Monoclonal Antibody, Unconjugated, Clone SPM278 ...

See all Laminin Receptor (67kDa) antibodies (7)

67kDa Laminin ... Home. Products. Products by type: Primary Antibodies. Secondary ... 67kDa Laminin Receptor antibody [SPM278] Flow Cyt, ICC/IF, IHC ...

All Prions | Abcam

All products relating to Prions ... Neuroscience abwire — the latest ... 67kDa Laminin Receptor antibody [SPM278] Flow Cyt, ICC/IF, IHC-P. Mouse monoclonal ...
Other TagsUmexElbowElbow
Breaking Medicine News(10 mins):Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 2Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 3Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 4Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 5Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 6Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 7Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 8Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 9Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 10Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 11Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 2Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 3Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 4Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 5Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 6Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 7Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 8Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 9Health News:Prescient Medical, Inc. CEO Patricia Scheller to Speak at 'The Value of Innovation in Health Care,' a Galen Institute Conference 2Health News:Help Young Cancer Patients Enjoy Christmas This Season 2Health News:The NHS to Improve Patient Care by Better Engaging Staff 2
Breaking Biology News(10 mins):Einstein receives high-risk/high-reward cancer research funding 2Einstein receives high-risk/high-reward cancer research funding 3Stem cells battle for space 2How to read brain activity? 2MEDA Receives FDA Approval of New ASTEPRO 28R 29 28azelastine HCl 29 Nasal Spray 0 15 25 the First and Only Once Daily Nasal Antihistamine 55998 1MEDA Receives FDA Approval of New ASTEPRO 28R 29 28azelastine HCl 29 Nasal Spray 0 15 25 the First and Only Once Daily Nasal Antihistamine 55998 2MEDA Receives FDA Approval of New ASTEPRO 28R 29 28azelastine HCl 29 Nasal Spray 0 15 25 the First and Only Once Daily Nasal Antihistamine 55998 3MEDA Receives FDA Approval of New ASTEPRO 28R 29 28azelastine HCl 29 Nasal Spray 0 15 25 the First and Only Once Daily Nasal Antihistamine 55998 4MEDA Receives FDA Approval of New ASTEPRO 28R 29 28azelastine HCl 29 Nasal Spray 0 15 25 the First and Only Once Daily Nasal Antihistamine 55998 5Providence Service Corporation to Present at the Baird 2009 Healthcare Conference on September 9 55994 1Providence Service Corporation to Present at the Baird 2009 Healthcare Conference on September 9 55994 2Derma Sciences To Present at Rodman 26 Renshaws Eleventh Annual Healthcare Conference 55990 1Derma Sciences To Present at Rodman 26 Renshaws Eleventh Annual Healthcare Conference 55990 2Derma Sciences To Present at Rodman 26 Renshaws Eleventh Annual Healthcare Conference 55990 3
Other Contentsleafletsleafletsleafletsleftleftleftleftleftleftleftleftleftleftzipperleucineleucocyte